Dr Reddy’s Laboratories enters into licensing agreement with Slayback Pharma EP News Bureau Aug 2, 2022 The partnership aims to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the US
100 colleges under PCI sign MOUs with LSSSDC EP News Bureau Dec 9, 2021 Over the course of next two-three years, LSSSDC expects all 1,800 PCI colleges offering BPharma to be fully integrated with it,…
Novartis in discussions to help produce COVID-19 vaccines, tests Reuters Jan 28, 2021 Novartis last year agreed to license two of Molecular Partners’ antiviral drugs that it hopes to use to treat COVID-19 patients
